Search

The article offers corporate profiles for clean-technology companies Sullivan Solar Power Inc., Genomatica Inc. and EDF Renewable Energy in San Diego, California. More than 80% of the revenue stream of EDF is from wind farms, but diversified into solar energy. Sullivan, which installs solar panels in rooftops, expects $34 million revenue for 2014 and $47 million in 2015. Genomatica has discovered a greener approach to manufacturing the industrial chemicals that finally turn into the plastics.

The article focuses on the report from professional services firm PriceWaterhouseCoopers LLP which shows that venture capital (VC) investment in life sciences sector in San Diego, California is on the upswing due to the positive effects of biotechnological market. It says that 14 life sciences companies the the city received a total of $156 million in venture funding. The table which list the 14 life sciences companies which received venture funding in the first quarter of 2014 is presented.

The article reports that the plan of drugmaker Lumena Pharmaceuticals Inc. to raise $75 million in an initial public offering (IPO) will be ended with acquisition. It states that Irish drugmaker Shire PLC has agreed to pay $260 million for Lumena, a biotechnology firm in San Diego, California. It relates the statement of Lumena Chief Executive Officer (CEO) Mike Grey about the IPO and acquisition.

The article focuses on the hair removal and care industry in San Diego, California. It features salons located in the area which offer hair care including Beauty By Dolly owned by Dolly Bakshai, Blink Lash Boutique owned by Janelle Koch, and Blow Pop Dry Bar owned by Mickel Bohi. Moreover, it states that the Beauty By Dolly salon can serve more than 20 customers per hour at low price.

The article discusses the performance of public companies in the biotechnology industry in San Diego, California. It presents the journal's list of the 50 largest local public companies, ranked by revenue in fiscal 2013 and the momentum built by the list which helped boost stock value across the board for city's life sciences companies. It mentions Quidel Corp., the second- highest revenue-generating public biotech in the region, and Sequenom Inc. which has shown marked change in 2014.

The article reports on chemical firm Genomatica Inc. and its role in promoting biorenewable products in San Diego, California. It mentions that the lack of market for biofuels encourages flexibility in companies utilizing natural substances such as corn, discarded sugar cane fibers and algae. It also notes its acquisition of accolades and funds from investors in petroleum industries.

The article reports on the launch of a new company Human Longevity Inc. by scientist J. Craig Venter in San Diego, California.

The article discusses the economic trends of monitoring devices from DexCom Inc., a company that manufactures, and distributes continuous glucose monitoring systems for diabetes management. It mentions that DexCom is one of the most highly valued medical device manufacturer in San Diego, California. It notes that the monitoring devices of DexCom has been approved by the Food and Drug Administration (FDA) in the U.S.

The article reports on the expansion of San Diego, California-based commercial health plan Sharp Health Plan of its market share in the individual market in the region. It is inferred that Sharp Heath Plan has enrolled 5,200 residents by the end of January 2013, from 4,126 by the end of the previous month. Information about the condition of other insurers participating in the health insurance exchange Covered California are offered.

The article reports that chief executive officer (CEO) David Wellis of San Diego Blood Bank seek to diversify revenue due to the decline of donor rates.

The article reports on the acquisition of a San Diego, California-based stem cell firm, Medistem Inc., by a Germantown, Maryland-based synthetic biology company, Intrexon Corp. for about $26 million. The ability and potency of Medistem's endometrial regenerative cells will be expanded by the genetic engineering capabilities of Intrexon, according to Alan Lewis of Medistem. Medistem's stockholders will receive 27 cents in exchange for each share of Medistem common stock in cash.

The article offers information on medical information technology which will help in cutting health care costs in 2014 in San Diego, California. It mentions that mobile health, including Bluetootth-enabled health trackers, location-aware telemonitoring systems, and wireless monitoring of vital signs, will be the biggest health care trend in 2014. It notes that telemedicine uses information and telecommunication technology to offer clinical health care at a distance.

The article reports on the program planned by the city of San Diego, California in cooperation with the utility firm San Diego Gas & Electric, the nonprofit organization CleanTech San Diego, and possibly with the semiconductor company Qualcomm Inc. to reduce electric expenditures.

The article focuses on the development on the regenerative medicine field in San Diego, California. It says that the sector has been raised with the $100 million grant by businessman T. Denny Sanford to he University of California, San Diego to set up a center for stem cell therapy research. It cites several regenerative medicine firms in the city including MediStem Inc., Cytori Therapeutics Inc., and International Stem Cell Corp.

The article reports that Celladon Corp. and Vital Therapies Inc. of San Diego, California have filed to go initial public offerings (IPO) with aims to raise $86.3 million. It relates the plan of Vital Therapies to use the proceeds of its IPO to further finance three Phase-3 clinical studies of its Elad medical device. On the other hand, Celladon plans to use the IPO funding in expanding clinical trials for its heart failure gene therapy.

The article focuses on the initial public offerings (IPO) by the biotechnology companies in San Diego, California. It says that there are several biotechnology companies which contributes to the IPO market, including Ambit Biosciences Corp., Conatus Pharmaceuticals Inc., and Sophiris Biosciences Inc. It states that there is a 62% increase in the IPO activity in 2013, based on Renaissance Capital LLC in Greenwich, Connecticut. It adds that the biotechnology companies' stock prices increased 34%.

The article reports that incentive programs for installation of solar projects may stop as more homes and businesses are adding rooftop solar panels. According to Holly Smithson, president of CleanTech San Diego, incentive programs for solar technology may deplete soon. Jackie Pitera stated that San Diego Gas & Electric and Pacific Gas and Electric have stopped accepting rebate applications for residential projects.

The article reports on the growth of the biotechnology research and development industry in San Diego, California from 2008 to 2012. It mentions the Waltham, Massachusetts-based Thermo Fisher Scientific Inc.'s acquisition of Carlsbad, California-based Life Technologies Corp. The article also notes the growth of other sectors including stem cell research, genomics and personal genetic medicine.

The article offers the insights of several businesswomen regarding the improvement of women-owned businesses in San Diego, California. According to Tamara Badkerhanian-Ganev of BSE Engineering Inc., women-run businesses in male-dominated field has increased while seminars and networking events help women become strong businesswomen with balance work life. Celia Hunter of construction management firm Hunter Pacific Group says that the construction industry is not anymore a male-dominated sector.

The article focuses on the union of Apricus Biosciences Inc. on the stock market of biotechnology in San Diego, California with $17.1 million secondary public offering. It says that Apricus is an $80 million market cap company which has developed the drug Vitaros for the treatment of erectile dysfunction. Chief financial officer Steve Martin adds that the $17 million offering of Apricus has allowed the company to increase its balance sheets to $30 million in cash.

The article reports on the competition among companies in San Diego, California in the lucrative high-end skincare market with the use of grounding in real science to promote their beauty wares. It states that other local biotechnology outfits learns that their science has true assess in the developing anti-aging skin cream market. It mentions that International Stem Cell Corp. was adopting technology from its medical research in formulating a new line of regenerative skin care products.

The article focuses on the impact of the Affordable Care Act (ACA) on businesses and employers in San Diego, California. California Medical Association officer Ted Mazer expresses that taxpayers and employers will shoulder the cost of the health insurance exchanges as one of the provisions of the ACA. He adds that health insurance premiums will likely increase due to cost-shifting to the private sector.

The article offers the insights of several hospital executives regarding the effect of the budget cut for the government health care subsidies in San Diego, California. According to Chris Van Gorder of Scripps Health, hospitals are the most affected in the fiscal budget cuts. Steven Escoboza of the Hospital Association of San Diego and Imperial Counties says that the $84 million budget cut will lead to the closure of certain services in the hospitals that treat Medicare patients.

The article focuses on the preparations being made by employers, individuals and healthcare professionals in San Diego, California for coverage changes under the Affordable Care Act (ACA) in 2013.

The article offers information on the International Biotech Convention of the Biotechnology Industry Organization (BIO) to be held at the San Diego Convention Center in San Diego, California from June 23-26, 2014.

The article offers San Diego, California health care and biotechnology industries news briefs as of June 16, 2014. Topics discussed include the $75 million initial public offering (IPO) filed by biotechnology company Pfenex Inc., the mergers and acquisitions in the industry, and the management changes in the hospital and health care leadership, like the departure of chief executive officer (CEO) Michael Covert at Palomar Health.

The article offers information related to business in San Diego, California including the partnership between Avalon Ventures with pharmaceutical company GlaxoSmithKline PLC, the expansion of Janssen Labs in South San Francisco, and the drug application filed by Adamis Pharmaceuticals Corp.

The article offers the author's insights on several companies that offers lice removal services in San Diego, California. Companies that were mentioned include Bug Adieu, Hair Fairies Inc., and Hair Daisies Lice Removal Services. Also mentioned are career and business developments such as Christopher Glass and Clifford Kubiak of the University of California who were elected at the American Academy of Arts and Sciences and Zogenix Inc.'s launched of the Zohydro painkiller.

The article discusses the impact the President Barack Obama's Jumpstart Our Business Startups, or JOBS, Act has on the biotechnology community in San Diego, California.

The article offers business-related news briefs in San Diego, California including the appointment of Greg McKee as chief executive officer (CEO), the opening of the Proton Therapy Center of ICYMI, and the plan of Acadia Pharmaceuticals Inc. to raise $182 million.

The article offers clinical news briefs in San Diego, California as of February 17, 2014 on topics including clinical trials for Huntington's disease, consolidation and merger of corporations, and events related to orphan product development.

The article reports on the $275 million received by the Sanford-Burnham Medical Research Institute in San Diego, California as a gift from an anonymous donor.

The article reports that Illumina Inc. of San Diego, California has brought the cost of sequencing of the human genome to 1,000 dollars with its HiSeqX Ten product.

The article discuses the strategic effort of San Diego, California to transform itself into an energy smart city in 2014 wherein such move is considered the biggest economic trend in clean technology in the region.

The article provides an overview of the biotechnology sector in San Diego, California in 2014, highlighting the growing number of activities planned by pharmaceutical firms in the region.

The article offers news briefs related to business in San Diego, California as of December 2013. Otonomy Inc., a company which is developing drugs for Meniere's disease treatment, has received designation from the U.S. Food and Drug Administration (FDA). Medical device manufacturer CareFusion Corp. will invest $100 million in Caesarea Medical Electronics, maker of infusion and syringe pumps. Accelrys Inc., a life sciences software developer, acquired Irish company Qumas for $50 million in cash.

The article offers information related to several businesses in San Diego, California. Illumina Inc. acquires NextBio Inc. based in Silicon Valley which used big data technology to advance gene study. Zogenix Inc. based in San Diego has received approval from the U.S. Food and Drug Administration for its extended release version of a narcotic painkiller hydrocodone. The stock of Nuvasive Inc. achieved a 52-week high, which closed at $31.40 on October 30, 2013.

The article reports on a study which suggests that employees in San Diego, California pay a higher share of their health care benefits compared to the national average. It reflects a study which predicts that health care costs in the area will increase by 7.5% in 2014. It states that the 2013 increases can be attributed to elements of the Affordable Care Act with variations on health reform's impact on employer groups. It also notes the increase of health care plan in the U.S. and in the area.

The article reports on the plan of taxi companies in San Diego, California to protest the new state regulations governing ride-sharing mobile applications which have raised concern among area taxi operators who are compelling to make requirements for ride-sharing more strict.

The article offers information related to businesses in San Diego, California as of September 23, 2013. The West Health Institute launches Center for Medical Interoperability Inc. cable television (TV) based in San Diego. Cardium Therapeutics Inc., pharmaceutical company based in San Diego, has launched a life insurance program for men with prostate cancer.

The article reports that the Rules and Economic Development Committee of the San Diego City Council in California is assigned to draft an ordinance regarding the proposed ban on the use of plastic in the region. Councilman Mark Kersey says that the committee need to know new regulations that might cost local businesses. It mentions that almost 80 cities and counties in the region have a single-use plastic bag ban in place.

The article reports on the success of San Diego-based health care leader Sharp Healthcare towards its Medicare Pioneer accountable care organization (ACO). It mentions that the ACO designed to reduce systemic Medicare costs by streamlining patient care. Senior vice president of business development and strategic planning Alison Fleury states that the Pioneer ACO model has high-risk but high-reward also.

The article offers news briefs related to pharmaceutical industry in San Diego, California as of August 19, 2013. Drugmaker Vical Inc. changes focus after the failure of anti-melanoma drug Allovectin's clinical trial. Biotech startup Arcturus Therapeutics Inc. has acquired 30 patents from Cambridge, Massachusetts-based Marina Biotech Inc. Stem cell transplant for blood cancer patients developer Fate Therapeutics Inc. proposed a $69 million initial public offering.

The article features Luth Research Inc., a privately held market research firm in San Diego, California owned by Roseanne Luth.

The article reports several activities in the biotechnology industry in San Diego, California. It mentions the good clinical data announced by Halozyme Therapeutics Inc. and Isis Pharmaceuticals Inc., which has resulted in increased stocks. It cites the completion of $21 million Series B funding for Acutus Medical Inc. It adds that Banyan Biomarkers Inc. has obtained $6 million Series A funding for the development of a diagnostic tool for traumatic brain injury.

The article reports on the continuous increase of gourmet food truck services in San Diego, California.

The article offers information related to the health care in San Diego, California. It highlights the development of bloodless medicine and surgery to treat Jehovah's Witnesses who refuse blood transfusion. It states that J. Craig Venter Institute Inc. has launched a mobile lab which aims to promote science, technology, engineering and mathematics (STEM) subjects to middle school students. It adds the 8th annual Convergence Summit of Wireless-Life Sciences Alliance to be held on May 29, 2013.

The article reports on the Netherlands-based Royal DSM NV which has expanded its presence in San Diego, California, through the opening of its $11 billion office and laboratory space, along with its partnership with the local company of Verenium Corp.

The article discusses the annual meeting of the American Academy of Neurology that was held in San Diego, California.

The article discusses the study by West Health Institute in San Diego, California, on interoperability which could reduce health care costs in the state. West Health Institute chief medical and science officer Joseph Smith says that the results of the study emphasize the potential benefits of medical device interoporerability. It also reveals that 90 percent of hospitals use more devices that could be incorporated with electronic medical records.